Serological examination in atherosclerosis and its vascular complications;Sérologické vyšetření u aterosklerózy a jejich cévních komplikací

Epidemiologie, Mikrobiologie, Imunologie

Volumn 52, Issue 4, 2003, Pages 142-146

  Pospíšil, Leopold ^a   Canderle J ^a   Zeman, K ^b   Stroblova H ^c   Medkova Z ^d  

^a Veterinarniho Lekarstvi ^*  (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^d Laborato e Bio Plus sro   (Czech Republic)

Author keywords

Atherogenesis; Cardiovascular diseases; Chlamydia pneumoniae; HSP60

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OUTER MEMBRANE PROTEIN; PROTEIN ANTIBODY;

ACUTE HEART INFARCTION; ANAMNESIS; ANGIOCARDIOGRAPHY; ANTIBODY DETECTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FREQUENCY ANALYSIS; HUMAN; IMMUNOFLUORESCENCE TEST; INCIDENCE; MAJOR CLINICAL STUDY; PATIENT MONITORING; SEROLOGY; UNSTABLE ANGINA PECTORIS; VASCULAR DISEASE;

EID: 0242350527     PISSN: 12107913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Burian, K., Kis, Z., Virok, D. et al.: Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 2002, 103, s. 1503-1508.
2. Byrne, G. I., Kalayoglu, M. V.: Chlamydia pneumoniae and atherosclerosis. Links to the disease proces. Amer Heart J. 1999, 138, s. 488-490.
3. Coles, K. A., Plant, A. J., Roley, T. V. et al.: Cardiovascular disease: an infection aetiology. Rev. Med. Microbiol. 1998, 9, s. 17-27.
4. Costa da, C. P., Kirschning, C. J., Busch, D. et al.: Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae. Europ. J. Immunol. 2002, 32, s. 2460-2470.
5. Dodet, B.: Infection and atherosclerosis. Amer. Heart J. 1999, 138, s. 417-418.
6. Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S. et al.: Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002, 105, s. 15-21.
7. Fong, I. W.: Emerging relations between infections disease and coronary artery disease and atherosclerosis. Canadian Med. Assoc. J. 2000, 163, s. 49-56.
8. Gupta, S.: Chronic infection in the aetiology of the atherosclerosis: focus on Chlamydia pneumoniae. Atherosclerosis 1999, 143, s. 1-6.
9. Hoppichler, F., Koch, T., Dzien, A. et al.: Prognostic value of antibody titre to heat shock protein 65 on cardiovascular events. Cardiology 2000, 94, s. 220-223.
10. Kalayoglu, M. V., Libby, P., Byrne, G. I.: Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. J. Amer. Med. Assoc. 2002, 288, s. 2724-2731.
11. Kol, A., Bourcier, T., Lichtman, A. H. et al.: Chlamydial and human heat shock protein 60 activates human vascular endothelium, smooth muscle cells and macrophages. J. Clin. Invest. 1999, 103, s. 571-577.
12. Kuo, C. C., Campbell, L. A.: Is Infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol. Med. Today 1998, 4, s. 426-430.
13. Libby, P., Ridker, P. M., Maseri, A.: Inflammation and atherosclerosis. Circulation 2002, 105, s. 1135-1143.
14. Mahdi, O. S., Horne, B. D., Mullen, K. et al.: Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease. Circulation 2002, 106, s. 1659-1663.
15. Medková, Z., Zeman, K., Pospíšil, L. et al.: Prevalence of antichlamydial antibodies in patients affected by acute myocardial infarction and unstable angina pectoris. In: Proceedings of the 10th International Symposium on Human Chlamydial Infection, Antalya, Turkey, June 16.-21. 2002, 475-478.
16. Pospíšil, L., Věžník, Z., Diblíková, I. et al.: Výskyt protilátek proti skupinovému chlamydiálnímu antigenu v lidské populaci ČR. Epidemiol. Mikrobiol. Imunol. 1997, 46, s. 13-17.
17. Pospíšil, L., Zeman, K., Štroblová, H. et al.: Protilátky proti proteinu tepelného šoku chlamydií (cHSP60) - marker rizika koronárního syndromu? Sborník XI. výročního sjezdu českce kardiol. spol., Brno, 11-14. 5. 2003, 75-76.
18. Rugonfalvi-Kiss, S., Enderesz, V., Madsen, H. O. et al.: Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 2002, 106, s. 1071-1076.
19. Saikku, P., Lainonen, M., Mattila, K.: Serological evidence of an association of a novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1998, 2, s. 983-986.
20. Staněk, V.: Úloha zánětu v etiologii aterosklerózy. Kapitoly z kardiologie 2000, 2, 1-5.
21. Veres, A., Fust, G., Smieja, M. et al.: Relationship of anti-60kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events. Circulation 2002, 106, s. 2775-2780.
22. Veres, A., Szamosi, T., Ablonczy, M. et al.: Complement activating antibodies against the human 60 kDa heat shock protein as a new independent family risk factor of coronary heart disease. Europ. J. Immunol. 2002, 32, s. 405-410.
23. Veres, A., Prochaszka, Z., Kilpinen, S. et al.: The promoter polymorphism of the IL-6 gene is associated with levels of antibodies to 60-kDa heat shock proteins. Immunogenetic 2002, 53, s. 851-856.
24. Věžník, Z., Pospíšil, L.: Chlamydiové infekce. IDVPZ Brno, 1997, 163 s.
25. Virok, D., Kis, Z., Karai, L. et al.: Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke, 2001, 32, s. 1973-1976.
26. Zeman, K., Pospíšil, L., Medková, Z. et al.: Účast chlamydiové infekce ve vztahu k ukazatelům lipemie v etiologii nestabilní anginy pectoris (UAP). Vnitřní lékařství, 2003, 49, s. 555-558.
27. Zeman, K., Pospíšil, L., Diblíková, I. et al.: Chlamydia pneumoniae a infarkt myokardu. Vnitřní lékařství, 2001, 47, 852-855.